Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines
Open Access
- 26 April 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (28) , 45874-45887
Abstract
Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell linesKeywords
This publication has 36 references indexed in Scilit:
- Autocrine prolactin induced by the Pten–Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathwaysGenes & Development, 2012
- Pancreatic endocrine tumorsLaboratory Investigation, 2011
- The Par-4/PTEN connection in tumor suppressionCell Cycle, 2009
- Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline TherapyThe Journal of Clinical Endocrinology & Metabolism, 2009
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- My approach to pathology of the pituitary glandJournal of Clinical Pathology, 2006
- Enhanced protein kinase B/Akt signalling in pituitary tumoursEndocrine-Related Cancer, 2005
- The prevalence of pituitary adenomasCancer, 2004
- Introduction to resistance to anticancer agentsOncogene, 2003
- Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein ComplexJournal of Biological Chemistry, 2001